29/#956 Cost-effectiveness of pembrolizumab for first-line treatment in patients with persistent, recurrent, or metastatic cervical cancer in the United States

Bradley Monk, Jennifer Boer, Frank Van Hees, Sophie Van Mens,Shilpi Swami,Dominic Muston,Cumhur Tekin, Steve Keefe,Matthew Monberg

Featured Printed Posters (Poster Rounds with the Professors)(2022)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要